EPISODE · Jun 13, 2020 · 33 MIN
Jason Meyenburg: CEO of Gemini Therapeutics
from BioBoss · host Jason Meyenburg
Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.
Embed this episode
Ready to play
Jason Meyenburg: CEO of Gemini Therapeutics
0:00
33:55
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of BioBoss?
This episode is 33 minutes long.
When was this BioBoss episode published?
This episode was published on June 13, 2020.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this BioBoss episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!